Search research articles
Contact Us
Filters
Showing results (131-140 of 186) with videos related to
Page
of 19
Sort By:
JCO Precision Oncology
|
July 17, 2018
Exceptional Chemotherapy Response in Metastatic Colorectal Cancer Associated With Hyper-Indel-Hypermutated Cancer Genome and Comutation of <i>POLD1</i> and <i>MLH1</i>
Manish R Sharma, James T Auman, Nirali M Patel, et al.
American Journal of Human Genetics
|
December 3, 2025
Liver single-nucleus multiome profiling reveals cell-type mechanisms for cardiometabolic traits
Abdalla A Alkhawaja, Kevin W Currin, Hannah J Perrin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 3, 2015
Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I-III Non-Small-Cell Lung Cancer
Dylan M Glubb, Laia Paré-Brunet, Eloisa Jantus-Lewintre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2016
Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance)
Maura N Dickler, William T Barry, Constance T Cirrincione, et al.
Plos Genetics
|
December 1, 2016
Genomic Characterization of Metformin Hepatic Response
Marcelo R Luizon, Walter L Eckalbar, Yao Wang, et al.
Pharmacogenetics and Genomics
|
March 20, 2019
An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance)
Federico Innocenti, Chen Jiang, Alexander B Sibley, et al.
International Journal of Cancer
|
September 16, 2021
Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens
Julia C F Quintanilha, Jin Wang, Alexander B Sibley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2019
Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance)
Chen Yuan, Kaori Sato, Bruce W Hollis, et al.
Journal of Personalized Medicine
|
December 15, 2018
The 9th Santorini Conference: Systems Medicine, Personalised Health and Therapy. "The Odyssey from Hope to Practice", Santorini, Greece, 30 September⁻3 October 2018
Sophie Visvikis-Siest, Vesna Gorenjak, Maria G Stathopoulou, et al.
Clinical Pharmacology and Therapeutics
|
October 20, 2018
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice
Giuseppe Toffoli, Federico Innocenti, Jerry Polesel, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 186) with videos related to
Sort By:
Page
of 19
JCO Precision Oncology
|
July 17, 2018
Exceptional Chemotherapy Response in Metastatic Colorectal Cancer Associated With Hyper-Indel-Hypermutated Cancer Genome and Comutation of <i>POLD1</i> and <i>MLH1</i>
Manish R Sharma, James T Auman, Nirali M Patel, et al.
American Journal of Human Genetics
|
December 3, 2025
Liver single-nucleus multiome profiling reveals cell-type mechanisms for cardiometabolic traits
Abdalla A Alkhawaja, Kevin W Currin, Hannah J Perrin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 3, 2015
Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I-III Non-Small-Cell Lung Cancer
Dylan M Glubb, Laia Paré-Brunet, Eloisa Jantus-Lewintre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2016
Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance)
Maura N Dickler, William T Barry, Constance T Cirrincione, et al.
Plos Genetics
|
December 1, 2016
Genomic Characterization of Metformin Hepatic Response
Marcelo R Luizon, Walter L Eckalbar, Yao Wang, et al.
Pharmacogenetics and Genomics
|
March 20, 2019
An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance)
Federico Innocenti, Chen Jiang, Alexander B Sibley, et al.
International Journal of Cancer
|
September 16, 2021
Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens
Julia C F Quintanilha, Jin Wang, Alexander B Sibley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2019
Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance)
Chen Yuan, Kaori Sato, Bruce W Hollis, et al.
Journal of Personalized Medicine
|
December 15, 2018
The 9th Santorini Conference: Systems Medicine, Personalised Health and Therapy. "The Odyssey from Hope to Practice", Santorini, Greece, 30 September⁻3 October 2018
Sophie Visvikis-Siest, Vesna Gorenjak, Maria G Stathopoulou, et al.
Clinical Pharmacology and Therapeutics
|
October 20, 2018
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice
Giuseppe Toffoli, Federico Innocenti, Jerry Polesel, et al.
Page
of 19